Anglo-Swedish drugmaker AstraZeneca has signed a deal worth up to $247 million with U.S. artificial intelligence (AI) ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

Drugs giant AstraZeneca faces a landmark High Court battle over accusations that some doses of its Covid-19 vaccine were 'defective' and claims of its efficacy were 'vastly overstated'. Two test ...

Nov 14 (Reuters) - Drugmaker AstraZeneca (AZN.L) said on Tuesday its cancer drug Imfinzi given along with chemoradiotherapy (CRT) failed to meet its main goal in a late-stage trial to treat ...

AstraZeneca has agreed to pay up to $2 billion for an experimental pill used to treat obesity and type 2 diabetes—the latest pharmaceutical firm to bet on treatment similar to popular weight ...

AstraZeneca PLC (LSE:AZN) had a mixed day of news, with the bright spots of a foray into anti-obesity drugs and an upgrade to its full-year outlook somewhat clouded by news about potential lawsuits ...

A former Playboy Playmate settled with The National Enquirer in a California state court Wednesday, releasing her from a contract agreement that she says blocked her from sharing her story of an ...

Shares of AstraZeneca rose as much as 4.2% in early trade after the company raised its full-year guidance for core earnings per share and total revenue excluding Covid-19 medicines after beating ...

AstraZeneca is scheduled to report results for the third quarter of the year on Thursday. Here is what you need to know: SALES: The Anglo-Swedish pharmaceutical giant is expected to report revenue ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is ...